Muhammad Butt, MD
Surgical Oncology · Plano, TXNPI 1619203403
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Intuitive Surgical at 59.6% of the total. Reporting peaked in 2019 at $3,975 and has fallen 95.9% since, to $164 in 2025.
Across 84 payments — averaging $82.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Medical Device Business Services, Inc.$1K
- Davol Inc.$267
- Abbott$205
- Medtronic$128
- TELA Bio, Inc.$126
- plus $797 from 23 others
What the payments were for
- Travel & lodging$1,86827%
- Food & beverage$2,02829%
- Education$3,00044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $4,109 |
| Medical Device Business Services, Inc. | 6 | $1,264 |
| Davol Inc. | 11 | $267 |
| Abbott | 7 | $205 |
| Medtronic | 5 | $128 |
| TELA Bio, Inc. | 7 | $126 |
| Johnson & Johnson | 2 | $82 |
| Tactile Systems Technology Inc | 4 | $69 |
| Integra Lifesciences Corporation | 4 | $66 |
| BD | 2 | $56 |
| AbbVie(2 entities) | 3 | $55 |
| Nestle Healthcare Nutrition Inc. | 2 | $46 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $42 |
| W. L. Gore & Associates, Inc. | 1 | $41 |
| Kls-martin L.p. | 1 | $41 |
| Polynovo North America LLC | 2 | $39 |
| Baxter Healthcare | 1 | $30 |
| Bioventus LLC | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Access Pro Medical, LLC | 1 | $24 |
| Biom'up France SAS | 1 | $24 |
| Acera Surgical, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $21 |
| Leica Microsystems Inc. | 1 | $19 |
| Cardinal Health 414 LLC | 1 | $18 |
| Kerecis Limited | 1 | $15 |
| Solventum Corporation | 1 | $15 |
| Acell, Inc. | 1 | $13 |
| Sirtex Medical Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,841
How this compares
$6,895 in reported general payments places this provider in the 75th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $95 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Plano
- Lynn CanavanPlano$11K
- Furrukh JabbarPlano$4K
- Allison DipasqualeDallas$272K
- Merrick RossHouston$216K
- John HardawayShenandoah$164K
- Steven CurleyTyler$162K
- Suhail SharifFort Worth$137K
- Alfredo Santillan GomezSan Antonio$125K
- Kelly HuntHouston$104K
- Adam YoppDallas$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.